Cargando…
Celecoxib in breast cancer prevention and therapy
Breast cancer has a high incidence worldwide. The results of substantial studis reveal that inflammation plays an important role in the initiation, development, and aggressiveness of many malignancies. The use of celecoxib, a novel NSAID, is repetitively associated with the reduced risk of the occur...
Autores principales: | Li, Jieqing, Hao, Qiongyu, Cao, Wei, Vadgama, Jaydutt V, Wu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208493/ https://www.ncbi.nlm.nih.gov/pubmed/30464589 http://dx.doi.org/10.2147/CMAR.S178567 |
Ejemplares similares
-
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
por: Cao, Wei, et al.
Publicado: (2019) -
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
por: Liu, Dingxie, et al.
Publicado: (2022) -
CCL2/CCR2 signaling in cancer pathogenesis
por: Hao, Qiongyu, et al.
Publicado: (2020) -
Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies
por: Hao, Qiongyu, et al.
Publicado: (2022) -
Wild-Type TP53 Predicts Poor Prognosis in Patients with Gastric Cancer
por: Deng, Wenhong, et al.
Publicado: (2021)